Literature DB >> 11010683

Chronic beryllium disease prevention program. Office of Environment, Safety and Health, Department of Energy. Final rule.

.   

Abstract

The Department of Energy (DOE) is today publishing a final rule to establish a chronic beryllium disease prevention program (CBDPP) to reduce the number of workers currently exposed to beryllium in the course of their work at DOE facilities managed by DOE or its contractors, minimize the levels of, and potential for, exposure to beryllium, and establish medical surveillance requirements to ensure early detection of the disease. This program improves and codifies provisions of a temporary CBDPP established by DOE directive in 1997.

Entities:  

Mesh:

Year:  1999        PMID: 11010683

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  5 in total

1.  Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response.

Authors:  Andrew P Fontenot; Brent E Palmer; Andrew K Sullivan; Fenneke G Joslin; Cara C Wilson; Lisa A Maier; Lee S Newman; Brian L Kotzin
Journal:  J Clin Invest       Date:  2005-09-08       Impact factor: 14.808

2.  Beryllium's public relations problem: protecting workers when there is no safe exposure level.

Authors:  David Michaels; Celeste Monforton
Journal:  Public Health Rep       Date:  2008 Jan-Feb       Impact factor: 2.792

3.  Illness absences among beryllium sensitized workers.

Authors:  Janice P Watkins; Elizabeth D Ellis; David J Girardi; Donna L Cragle; Bonnie S Richter
Journal:  Am J Public Health       Date:  2014-09-11       Impact factor: 9.308

4.  Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease.

Authors:  Margaret M Mroz; Lisa A Maier; Matthew Strand; Lori Silviera; Lee S Newman
Journal:  Am J Ind Med       Date:  2009-10       Impact factor: 2.214

5.  Chronic beryllium disease and sensitization at a beryllium processing facility.

Authors:  Kenneth Rosenman; Vicki Hertzberg; Carol Rice; Mary Jo Reilly; Judith Aronchick; John E Parker; Jackie Regovich; Milton Rossman
Journal:  Environ Health Perspect       Date:  2005-10       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.